Norris Perne & French’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.51M | Sell |
|
|||||
|
2025
Q2 | $18.3M | Sell |
|
|||||
|
2025
Q1 | $19.4M | Buy |
|
|||||
|
2024
Q4 | $23.3M | Sell |
|
|||||
|
2024
Q3 | $25.6M | Sell |
|
|||||
|
2024
Q2 | $27M | Buy |
|
|||||
|
2024
Q1 | $34.9M | Sell |
|
|||||
|
2023
Q4 | $31.2M | Buy |
|
|||||
|
2023
Q3 | $20.4M | Buy |
|
|||||
|
2023
Q2 | $21.6M | Buy |
|
|||||
|
2023
Q1 | $20.5M | Buy |
|
|||||
|
2022
Q4 | $21.9M | Sell |
|
|||||
|
2022
Q3 | $20.3M | Buy |
|
|||||
|
2022
Q2 | $21.5M | Buy |
|
|||||
|
2022
Q1 | $21.3M | Buy |
|
|||||
|
2021
Q4 | $27.7M | Sell |
|
|||||
|
2021
Q3 | $30.9M | Buy |
|
|||||
|
2021
Q2 | $27.6M | Sell |
|
|||||
|
2021
Q1 | $24M | Sell |
|
|||||
|
2020
Q4 | $26.9M | Sell |
|
|||||
|
2020
Q3 | $24.5M | Sell |
|
|||||
|
2020
Q2 | $19.1M | Sell |
|
|||||
|
2020
Q1 | $14M | Buy |
|
|||||
|
2019
Q4 | $15.1M | Buy |
|
|||||
|
2019
Q3 | $13M | Sell |
|
|||||
|
2019
Q2 | $14.2M | Buy |
|
|||||
|
2019
Q1 | $13.4M | Sell |
|
|||||
|
2018
Q4 | $10.8M | Sell |
|
|||||
|
2018
Q3 | $12.9M | Sell |
|
|||||
|
2018
Q2 | $10.9M | Sell |
|
|||||
|
2018
Q1 | $10.6M | Sell |
|
|||||
|
2017
Q4 | $11M | Buy |
|
|||||
|
2017
Q3 | $10.7M | Buy |
|
|||||
|
2017
Q2 | $9.94M | Buy |
|
|||||
|
2017
Q1 | $8.38M | Buy |
|
|||||
|
2016
Q4 | $6.38M | Buy |
|
|||||
|
2016
Q3 | $6.95M | Buy |
|
|||||
|
2016
Q2 | $3.28M | Buy |
|
|||||
|
2016
Q1 | $2.69M | Buy |
|